Arrowpoint Investment Partners »

Neumora Therapeutics shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $31k 16k 1.95

More positions owned by Arrowpoint Investment Partners

Ishares Tr Expanded Tech Call Option (IGV)
Kraneshares Trust Csi Chi Internet (KWEB)
Alphabet Cap Stk Cl A (GOOGL)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Ishares Msci Brazil Etf Call Option (EWZ)
Ase Technology Hldg Sponsored Ads (ASX)
Ionis Pharmaceuticals (IONS)
Neurocrine Biosciences (NBIX)
Axsome Therapeutics (AXSM)
BioMarin Pharmaceutical (BMRN)
Ascendis Pharma A/s Sponsored Adr (ASND)
Ptc Therapeutics I (PTCT)
Pfizer (PFE)
Regeneron Pharmaceuticals (REGN)
Johnson & Johnson (JNJ)

View all positions for Arrowpoint Investment Partners

Top funds holding Neumora Therapeutics

Softbank Group Corp
Siren
Perceptive Advisors
Vanguard Group
MIC Capital Management UK
Vanguard Capital Management
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Millennium Management
ICONIQ Capital
Lunate Capital
BlackRock
Two Sigma Investments
Johnson & Johnson
Renaissance Technologies

View all funds holding Neumora Therapeutics